Dasatinib tablets 50mg “SAWAI” from Sawai Pharmaceutical is a medication containing dasatinib, used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This 50mg 1 tablet formulation has a YJ code of 4291020F2058.
Dasatinib tablets 50mg “SAWAI”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
